News & Insights
The Latest From BCC
Explore news about Blitzer, Clancy & Company and our partners. Members of the media may contact us for more information.
ABS Bio Acquires Cureline, Broadening Access to Biospecimens & Streamlining Execution From End to End
Blitzer, Clancy & Company represented Cureline, a leading provider of specimen procurement and histology services to the pharmaceutical and life sciences industries.
Elevate Expands Global Creative Leadership With Strategic Acquisitions of Downstream and GA to Deliver Creative Experiences Across Brands, Sports, and Luxury Hospitality
Blitzer, Clancy & Company represented design studios Downstream and GA.
Blitzer, Clancy & Company Co-Founder Michael Blitzer Awarded Prestigious Strathclyde Medal for Strategic Partnership and Impact
Michael’s engagement with Strathclyde spans more than two decades and reflects a shared commitment to advancing institutions as engines of economic and societal progress.
3 Boomerang Capital Announces Strategic Growth Investment in Analytical Biological Services Inc.
Blitzer, Clancy & Company advised ABS, a leading provider of biopharma biomaterial services.
Stay a Step Ahead
Get the latest news and insights from Blitzer, Clancy & Company.